Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
Condition(s):Chronic Myelogenous LeukemiaLast Updated:October 14, 2009Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Myelogenous LeukemiaLast Updated:October 14, 2009Completed
Condition(s):CML; Philadelphia Chromosome Positive (Ph+); Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough LevelsLast Updated:May 20, 2021Terminated
Condition(s):Philadelphia Chromosome Positive; Chronic Myelogenous Leukemia in Chronic PhaseLast Updated:April 8, 2016Completed
Condition(s):Chronic Myelogenous Leukemia in Chronic PhaseLast Updated:November 23, 2009Completed
Condition(s):Chronic Myelogenous Leukemia – Chronic PhaseLast Updated:August 18, 2021Terminated
Condition(s):Myeloid Leukemia, Chronic, Chronic-PhaseLast Updated:August 25, 2016Completed
Condition(s):Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaLast Updated:March 21, 2024Active, not recruiting
Condition(s):Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaLast Updated:December 20, 2023Active, not recruiting
Condition(s):Chronic Myelogenous LeukemiaLast Updated:May 28, 2019Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:August 7, 2014Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.